Real-time enrollment status for this breast ductal carcinoma in situ clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:17 PM UTC
| NCT Number | NCT04144023 |
| Recruiting Status | Recruiting |
| Condition | Breast Ductal Carcinoma In Situ |
| Phase | Clinical Trial |
| Target Enrollment | 43 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | March 5, 2026 (Mar 5, 2026) |
As of July 13, 2026: Clinical trial NCT04144023 is currently recruiting participants. This clinical trial study for breast ductal carcinoma in situ is actively seeking new participants at 2 locations across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04144023 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04144023 was last updated Mar 5, 2026 (March 5, 2026). HelloStudys verifies this status automatically.